Search

Author/Creator Lalezari, Ferry

1. 18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial. (April 2023)

Authors:
Cooke, Saskia A.; de Ruysscher, Dirk; Reymen, Bart; Lambrecht, Maarten; Fredberg Persson, Gitte; Faivre-Finn, Corinne; Dieleman, Edith M.T.; Lewensohn, Rolf; van Diessen, Judi N.A.; Sikorska, Karolina; Lalezari, Ferry; Vogel, Wouter; van Elmpt, Wouter; Damen, Eugène M.F.; Sonke, Jan-Jakob; Belder...
Journal:
Radiotherapy and oncology
Issue:
Volume 181(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice. Issue 2 (3rd August 2022)

Authors:
Samsom, Kris G; Schipper, Luuk J; Roepman, Paul; Bosch, Linda JW; Lalezari, Ferry; Klompenhouwer, Elisabeth G; de Langen, Adrianus J; Buffart, Tineke E; Riethorst, Immy; Schoenmaker, Lieke; Schout, Daoin; van der Noort, Vincent; van den Berg, Jose G; de Bruijn, Ewart; van der Hoeven, Jacobus JM; ...
Journal:
Journal of pathology
Issue:
Volume 258:Issue 2(2022)
Page Start:
179
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial. Issue 3 (March 2019)

Authors:
Disselhorst, Maria J; Quispel-Janssen, Josine; Lalezari, Ferry; Monkhorst, Kim; de Vries, Jeltje F; van der Noort, Vincent; Harms, Emmy; Burgers, Sjaak; Baas, Paul
Journal:
Lancet
Issue:
Volume 7:Issue 3(2019)
Page Start:
260
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM). Issue 3 (June 2020)

Authors:
Rozeman, Elisa A.; Prevoo, Warner; Meier, Mark A.J.; Sikorska, Karolina; Van, Trieu M.; van de Wiel, Bart A.; van der Wal, Jacqueline E.; Mallo, Henk A.; Grijpink-Ongering, Lindsay G.; Broeks, Annegien; Lalezari, Ferry; Reeves, Jason; Warren, Sarah; van Thienen, Johannes V.; van Tinteren, Harm; H...
Journal:
Melanoma research
Issue:
Volume 30:Issue 3(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial. Issue 6 (June 2021)

Authors:
de Gooijer, Cornedine J; van der Noort, Vincent; Stigt, Jos A; Baas, Paul; Biesma, Bonne; Cornelissen, Robin; van Walree, Nico; van Heemst, Robbert C; Soud, Magdolen Youssef-El; Groen, Harry J M; den Brekel, Agnes J Staal-van; Buikhuisen, Wieneke A; Bootsma, Gerben P; Dammeijer, Floris; van Tinte...
Journal:
Lancet
Issue:
Volume 9:Issue 6(2021)
Page Start:
585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗